CD19 and cancer: Similar killing assays were performed using human CAR T cells and human Nalm6 cancer cells (E-T ratios of 1:1 and 1:10), which further supported these findings: Even at concentrations of 200 nM, the CD19 PET probe did not impair cytotoxicity of human CAR T cells (fig.